Journal article icon

Journal article

In Vitro and In Vivo Evaluation of Nitroxoline as an Effective Antimicrobial Alternative to Poultry Production

Abstract:
BackgroundAntimicrobial resistance is a major global challenge that is exacerbated by extensive antibiotic use in livestock farming. Identifying effective alternatives to widely used human antibiotics in animal production is vital to safeguard vital human medicines and ensure sustainable food systems. Here we describe studies identifying nitroxoline (NTX) as a promising antimicrobial candidate for use in poultry production.MethodsThe antibacterial activity and resistance potential of NTX were assessed in vitro. In vivo studies in chickens evaluated tolerance, therapeutic efficacy in Salmonella-infected birds, pharmacokinetics, tissue residue depletion, growth performance, and effects on caecal microbiota. NTX was administered in-feed at different dose levels. Pharmacokinetic parameters and withdrawal periods were determined, and caecal microbiota composition was analysed using ribosomal RNA 16S sequencing.ResultsNTX exhibits potent broad-spectrum antibacterial activity in vitro and low levels of resistance. NTX is well-tolerated in chickens at 500 mg/kg in-feed for 7 days and substantially reduces liver bacterial loads at 100 mg/kg in Salmonella-infected chickens. Pharmacokinetic and residue analyses reveal NTX manifests rapid absorption and distribution, high oral bioavailability (86%), and efficient tissue clearance with a 17-day withdrawal period required for skin-plus-fat clearance. NTX supplementation is associated with increased weight gain and improved feed efficiency compared to the control group, with performance comparable to chlortetracycline. Microbiota analysis indicates modulation of caecal bacterial communities, including increased Faecalibacterium and Lactobacillus.ConclusionsThese results indicate that NTX is a viable alternative to important human antibiotics widely deployed in poultry production, offering a potential approach to minimise antimicrobial resistance whilst maintaining animal health and food biosafety.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.3390/antibiotics15010062

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0009-0003-3613-4027
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-5462-7026
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-1078-3371
More by this author
Role:
Author
ORCID:
0000-0002-3170-9755
More by this author
Institution:
University of Oxford
Role:
Author


Publisher:
MDPI
Journal:
Antibiotics More from this journal
Volume:
15
Issue:
1
Pages:
62
Publication date:
2026-01-06
Acceptance date:
2025-12-29
DOI:
EISSN:
2079-6382
ISSN:
2079-6382
Pmid:
41594099


Language:
English
Keywords:
Pubs id:
2357636
UUID:
uuid_f5d8bf96-dd72-4e32-88c4-25944d7bd096
Local pid:
pubs:2357636
Source identifiers:
3727827
Deposit date:
2026-02-05
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP